ADAMANTIDIS, M. M., B. M. DUMOTIER, J. F. CARON u. R. BORDET (1998):
Sparfloxacin but not levofloxacin or ofloxacin prolongs cardiac repolarization in rabbit Purkinje fibers.
Fundam Clin Pharmacol 12, 70-76
ADLER, M. W., C. H. LIN, S. H. KEINATH, S. BRAVERMAN u. E. B. GELLER (1976):
Anticonvulsant action of acute morphine administration in rats.
J Pharmacol Exp Ther 198, 655-660
AKAHANE, K., M. SEKIGUCHI, T. UNE u. Y. OSADA (1989):
Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.
Antimicrob Agents Chemother 33, 1704-1708
AMBRISKO, T. D., C. B. JOHNSON u. P. CHAMBERS (2011):
Effect of alfaxalone infusion on the electroencephalogram of dogs anaesthetized with halothane.
Vet Anaesth Analg 38, 529-535
BARONI, E. E., S. RUBIO, C. RODRIGUEZ, J. J. DE LUCAS, H. FERNANDEZ u. M.
S. ANDRES (2011):
Pharmacokinetic interactions of marbofloxacin with anti-inflammatory drugs in buffalo calves.
Vet Rec 169, 182
BERENDT, M., H. HOGENHAVEN, A. FLAGSTAD u. M. DAM (1999):
Electroencephalography in dogs with epilepsy: similarities between human and canine findings.
Acta Neurol Scand 99, 276-283
BERGAMASCO, L., A. ACCATINO, L. PRIANO, G. NEIGER-AESCHBACHER, S.
CIZINAUSKAS u. A. JAGGY (2003):
Quantitative electroencephalographic findings in beagles anaesthetized with propofol.
Vet J 166, 58-66
BERGH, M. S. u. S. C. BUDSBERG (2005):
The coxib NSAIDs: potential clinical and pharmacologic importance in veterinary medicine.
J Vet Intern Med 19, 633-643
BERMAN, E. F. u. M. W. ADLER (1984):
The anticonvulsant effect of opioids and opioid peptides against maximal electroshock seizures in rats.
Evaluation of the concentration of marbofloxacin in alveolar macrophages and pulmonary epithelial lining fluid after administration in dogs.
Am J Vet Res 66, 1770-1774
BORGES, M., R. MARINI FILHO, C. B. LAPOSY, P. T. GUIMARAES-OKAMOTO, M.
P. CHAVES, A. N. VIEIRA u. A. MELCHERT (2013):
Nonsteroidal anti-inflammatory therapy: changes on renal function of healthy dogs.
Acta Cir Bras 28, 842-847
BOSTROM, I. M., G. C. NYMAN, P. E. LORD, J. HAGGSTROM, B. E. JONES u. H.
P. BOHLIN (2002):
Effects of carprofen on renal function and results of serum biochemical and hematologic analyses in anesthetized dogs that had low blood pressure during anesthesia.
Am J Vet Res 63, 712-721
BOTTING, R. u. S. S. AYOUB (2005):
COX-3 and the mechanism of action of paracetamol/acetaminophen.
Prostaglandins Leukot Essent Fatty Acids 72, 85-87 BOTTING, R. M. (2000):
Mechanism of action of acetaminophen: is there a cyclooxygenase 3?
Clin Infect Dis 31 Suppl 5, S202-210 BOTTING, R. M. (2010):
Vane's discovery of the mechanism of action of aspirin changed our understanding of its clinical pharmacology.
Pharmacol Rep 62, 518-525
BOWIE, W. R., V. WILLETTS u. P. J. JEWESSON (1989):
Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin.
Antimicrob Agents Chemother 33, 1778-1782
BRAUER, C., S. B. KASTNER, H. C. SCHENK, J. TUNSMEYER u. A. TIPOLD (2011):
Electroencephalographic recordings in dogs: Prevention of muscle artifacts and evaluation of two activation techniques in healthy individuals.
Res Vet Sci 90, 306-311
BRESALIER, R. S., R. S. SANDLER, H. QUAN, J. A. BOLOGNESE, B. OXENIUS, K.
HORGAN, C. LINES, R. RIDDELL, D. MORTON, A. LANAS, M. A. KONSTAM u. J.
A. BARON (2005):
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.
N Engl J Med 352, 1092-1102
BRIDEAU, C., C. VAN STADEN u. C. C. CHAN (2001):
In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats.
Am J Vet Res 62, 1755-1760
BUDSBERG, S. u. J. KIRSCH (2001):
Antibiotic prophylaxis in veterinary orthopaedic surgery.
Vet Comp Orthop Traumatol 14, 185-189
BUFALARI, A., C. ADAMI, G. ANGELI u. C. E. SHORT (2007):
Pain assessment in animals.
Vet Res Commun 31 Suppl 1, 55-58
CARBONE, M., M. G. PENNISI, M. MASUCCI, A. DE SARRO, M. GIANNONE u. M.
T. FERA (2001):
Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates.
Vet Microbiol 81, 79-84
CARLOTTI, D. N., E. GUAGUERE, D. PIN, P. JASMIN, E. THOMAS u. V. GUIRAL (1999):
Therapy of difficult cases of canine pyoderma with marbofloxacin: a report of 39 dogs.
J Small Anim Pract 40, 265-270
CHANDRASEKHARAN, N. V., H. DAI, K. L. ROOS, N. K. EVANSON, J. TOMSIK, T.
S. ELTON u. D. L. SIMMONS (2002):
COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression.
Proc Natl Acad Sci U S A 99, 13926-13931
CHANOIT, G. P., M. SCHNEIDER, F. WOEHRLE u. H. P. LEFEBVRE (2005):
Effect of marbofloxacin on cardiovascular variables in healthy isoflurane-anesthetized dogs.
Am J Vet Res 66, 2090-2094
CHENEL, M., S. MARCHAND, A. DUPUIS, I. LAMARCHE, J. PAQUEREAU, C.
PARIAT u. W. COUET (2004):
Simultaneous central nervous system distribution and pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of norfloxacin administered at a convulsant dose in rats.
Br J Pharmacol 142, 323-330
CHERNIK, D. A., D. GILLINGS, H. LAINE, J. HENDLER, J. M. SILVER, A. B.
DAVIDSON, E. M. SCHWAM u. J. L. SIEGEL (1990):
Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale:
study with intravenous midazolam.
J Clin Psychopharmacol 10, 244-251 CHRIST, W. (1990):
Central nervous system toxicity of quinolones: human and animal findings.
J Antimicrob Chemother 26 Suppl B, 219-225
CLARK, T. P., C. CHIEFFO, J. C. HUHN, E. L. NIMZ, C. WANG u. M. G. BOY (2003):
The steady-state pharmacokinetics and bioequivalence of carprofen administered orally and subcutaneously in dogs.
J Vet Pharmacol Ther 26, 187-192
CRON, M., C. ZEMIRLINE, J. BERANGER u. V. PRIVAT (2014):
Palatability evaluation study of a new oral formulation of marbofloxacin in cats.
Vet Rec 175, 88
CURFMAN, G. D., S. MORRISSEY u. J. M. DRAZEN (2005):
Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8.
N Engl J Med 353, 2813-2814
DEMOLIS, J. L., A. CHARRANSOL, C. FUNCK-BRENTANO u. P. JAILLON (1996):
Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers.
Br J Clin Pharmacol 41, 499-503 EGER, E. I., 2ND (1994):
New inhaled anesthetics.
Anesthesiology 80, 906-922 EMA (2011):
Cimalgex: EPAR - Public assessment report.
[Internet: URL:
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/veterinary/medicine
EMMERICH, I. U. (2012):
Neue Arzneimittel für Kleintiere 2011.
Tierarztl Prax Kleintiere 40, 351-362
ERON, L. J., L. HARVEY, D. L. HIXON u. D. M. PORETZ (1985):
Ciprofloxacin therapy of infections caused by Pseudomonas aeruginosa and other resistant bacteria.
Antimicrob Agents Chemother 28, 308-310
FERA, M. T., E. LOSI, M. G. PENNISI, M. MASUCCI, M. GIANNONE, T. L.
MAUGERI u. M. CARBONE (2002):
Potency and postantibiotic effect of four fluoroquinolones against feline Pasteurella multocida isolates.
Vet Rec 151, 180-181
FERRERO, L., B. CAMERON, B. MANSE, D. LAGNEAUX, J. CROUZET, A.
FAMECHON u. F. BLANCHE (1994):
Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
Mol Microbiol 13, 641-653
FINCO, D. R. u. J. R. DUNCAN (1976):
Evaluation of blood urea nitrogen and serum creatinine concentrations as indicators of renal dysfunction: a study of 111 cases and a review of related literature.
J Am Vet Med Assoc 168, 593-601
Pain management in small animal medicine.
1. Aufl., CRC Press, Boca Raton
FOX, S. M. u. S. A. JOHNSTON (1997):
Use of carprofen for the treatment of pain and inflammation in dogs.
J Am Vet Med Assoc 210, 1493-1498 FREY, H.-H. u. W. LÖSCHER (2009):
Lehrbuch der Pharmakologie und Toxikologie für die Veterinärmedizin.
2. Aufl., Enke Verlag, Stuttgart GAST, L. (1964):
Influence of aspirin on haemostatic parameters.
Ann Rheumatic Dis 23, 500-504
GELATT, K. N., A. VAN DER WOERDT, K. L. KETRING, S. E. ANDREW, D. E.
BROOKS, D. J. BIROS, H. M. DENIS u. T. J. CUTLER (2001):
Enrofloxacin-associated retinal degeneration in cats.
Vet Ophthalmol 4, 99-106
GELLERT, M., K. MIZUUCHI, M. H. O'DEA u. H. A. NASH (1976):
DNA gyrase: an enzyme that introduces superhelical turns into DNA.
Proc Natl Acad Sci U S A 73, 3872-3876
GERVASONI, C., D. CATTANEO, F. S. FALVELLA, P. VITIELLO, S. CHELI, L.
MILAZZO, E. CLEMENTI u. A. RIVA (2013):
Levofloxacin-induced seizures in a patient without predisposing risk factors: the impact of pharmacogenetics.
Eur J Clin Pharmacol 69, 1611-1613 GRADY, M. M. u. S. M. STAHL (2013):
Novel agents in development for the treatment of depression.
CNS Spectr 18, 34-41
GRANDEMANGE, E., S. FOURNEL u. F. WOEHRLÉ (2012):
Efficacy and safety of cimicoxib in the control of peri-operative pain in dogs.
In: BSAVA Congress, April 11 to 15, Birmingham, UK, 522-523 GRANDEMANGE, E., S. FOURNEL u. F. WOEHRLÉ (2013):
Efficacy and safety of cimicoxib in the control of perioperative pain in dogs.
J Small Anim Pract 54, 304-312
GRUET, P., P. RICHARD, E. THOMAS u. A. AUTEFAGE (1997):
Prevention of surgical infections in dogs with a single intravenous injection of marbofloxacin: an experimental model.
Vet Rec 140, 199-202 GRÜGER, T. (2004):
Die Rolle von Topoisomerase IV als Zielstruktur für Inhibitoren in E. coli sowie die Transkriptionskontrolle ihrer Strukturgene parC und parE.
Hannover, tierärztl. Hochsch., Diss
HASANI, A. S., M. SOLJAKOVA, M. H. JAKUPI u. S. Z. USTALAR-OZGEN (2011):
Preemptive analgesic effect of diclofenac: experimental study in rats.
Middle East J Anaesthesiol 21, 355-360
HERSH, E. V., E. T. LALLY u. P. A. MOORE (2005):
Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?
Curr Med Res Opin 21, 1217-1226
HIROSE, M., H. MIWA, O. KOBAYASHI, K. OSHIDA, H. MISAWA, A. KUROSAWA, S. WATANABE u. N. SATO (2002):
Inhibition of proliferation of gastric epithelial cells by a cyclooxygenase 2 inhibitor, JTE522, is also mediated by a PGE2-independent pathway.
Aliment Pharmacol Ther 16 Suppl 2, 83-89 HOFFMANN, M. (2010):
Adaptation zweier an Katzen evaluierter Schmerztest (mechanisch und thermisch) an den Hund und deren Evaluierung mittels zweier Opioide und eines NSAID.
Hannover, tierärztl. Hochsch., Diss
HOLLIDAY, T. A. u. D. C. WILLIAMS (1998):
Interictal paroxysmal discharges in the electroencephalograms of epileptic dogs.
Clin Tech Small Anim Pract 13, 132-143
HOLTON, L., J. REID, E. M. SCOTT, P. PAWSON u. A. NOLAN (2001):
Development of a behaviour-based scale to measure acute pain in dogs.
Vet Rec 148, 525-531
HONG, T. T., J. HUANG, T. D. BARRETT u. B. R. LUCCHESI (2008):
Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis.
Am J Physiol Heart Circ Physiol 294, H145-155 HORI, S., J. KIZU u. M. KAWAMURA (2003):
Effects of anti-inflammatory drugs on convulsant activity of quinolones: a comparative study of drug interaction between quinolones and anti-inflammatory drugs.
J Infect Chemother 9, 314-320
INGVAST-LARSSON, C., A. HOLGERSSON, U. BONDESSON, A. S. LAGERSTEDT u. K. OLSSON (2010):
Clinical pharmacology of methadone in dogs.
Vet Anaesth Analg 37, 48-56
JARUPONGPRAPA, S., P. USSAVASODHI u. W. KATCHAMART (2013):
Comparison of gastrointestinal adverse effects between cyclooxygenase-2 inhibitors and non-selective, non-steroidal anti-inflammatory drugs plus proton pump inhibitors:
a systematic review and meta-analysis.
J Gastroenterol 48, 830-838 JASPER, H. H. (1958):
The ten twenty electrode system of the international federation.
Electroencephalogr Clin Neurophysiol 10, 371-375
Assessment of the effects of combination therapy with ciprofloxacin and fenbufen on the central nervous systems of healthy volunteers by quantitative electroencephalography.
Antimicrob Agents of Chemother 42, 1256-1258
KARGMAN, S., S. CHARLESON, M. CARTWRIGHT, J. FRANK, D. RIENDEAU, J.
MANCINI, J. EVANS u. G. O'NEILL (1996):
Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts.
Gastroenterology 111, 445-454
KAY-MUGFORD, P., S. J. BENN, J. LAMARRE u. P. CONLON (2000):
In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs.
Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity.
Toxicol Pathol 26, 612-620
KHODURSKY, A. B., E. L. ZECHIEDRICH u. N. R. COZZARELLI (1995):
Topoisomerase IV is a target of quinolones in Escherichia coli.
Proc Natl Acad Sci U S A 92, 11801-11805
KIM, J., H. OHTANI, M. TSUJIMOTO u. Y. SAWADA (2009):
Quantitative comparison of the convulsive activity of combinations of twelve fluoroquinolones with five nonsteroidal antiinflammatory agents.
Drug Metab Pharmacokinet 24, 167-174
KIM, T. W., B. LEBKOWSKA-WIERUSZEWSKA, H. OWEN, H. I. YUN, C. J.
KOWALSKI u. M. GIORGI (2014):
Pharmacokinetic profiles of the novel COX-2 selective inhibitor cimicoxib in dogs.
Vet J 200, 77-81
KING, D. E., R. MALONE u. S. H. LILLEY (2000):
New classification and update on the quinolone antibiotics.
Am Fam Physician 61, 2741-2748
KITA, H., H. MATSUO, H. TAKANAGA, J. KAWAKAMI, K. YAMAMOTO, T. IGA, M.
NAITO, T. TSURUO, A. ASANUMA, K. YANAGISAWA u. Y. SAWADA (1999):
In vivo and in vitro toxicodynamic analyses of new quinolone-and nonsteroidal anti-inflammatory drug-induced effects on the central nervous system.
Antimicrob Agents Chemother 43, 1091-1097
KLEM, G. H., H. O. LUDERS, H. H. JASPER u. C. ELGER (1999):
The ten-twenty electrode system of the International Federation. The International Federation of Clinical Neurophysiology.
Electroencephalogr Clin Neurophysiol Suppl 52, 3-6 KLEMM, W. R. (1989):
Electroencephalography in the diagnosis of epilepsy.
Probl Vet Med 1, 535-557
KO, J. C., D. N. LANGE, R. E. MANDSAGER, M. E. PAYTON, C. BOWEN, A.
KAMATA u. W. C. KUO (2000a):
Effects of butorphanol and carprofen on the minimal alveolar concentration of isoflurane in dogs.
J Am Vet Med Assoc 217, 1025-1028
KO, J. C., T. MIYABIYASHI, R. E. MANDSAGER, T. G. HEATON-JONES u. D. F.
MAURAGIS (2000b):
Renal effects of carprofen administered to healthy dogs anesthetized with propofol and isoflurane.
J Am Vet Med Assoc 217, 346-349
KRIEGLSTEIN, J., H. RIEGER u. H. SCHUTZ (1979):
Effects of chlorpromazine and some of its metabolites on the EEG and on dopamine metabolism of the isolated perfused rat brain.
Eur J Pharmacol 56, 363-370
KROPF, J., R. C. BENNETT, G. SELF, P. MONTICELLI u. V. HUUSKONEN (2014):
Efficacy and safety of cimicoxib in the control of perioperative pain in dogs: a critique.
J Small Anim Pract 55, 652-653
KUKANICH, B. u. S. L. BORUM (2008):
The disposition and behavioral effects of methadone in Greyhounds.
Vet Anaesth Analg 35, 242-248
KULKA, A. M., K. A. OTTO, C. BERGFELD, M. BEYERBACH u. S. B. KASTNER (2012):
Effects of isoflurane anesthesia with and without dexmedetomidine or remifentanil on quantitative electroencephalographic variables before and after nociceptive stimulation in dogs.
Am J Vet Res 73, 602-609
LAREDO, F. G., E. BELDA, J. MURCIANO, M. ESCOBAR, A. NAVARRO, K. J.
ROBINSON u. R. S. JONES (2004):
Comparison of the analgesic effects of meloxicam and carprofen administered preoperatively to dogs undergoing orthopaedic surgery.
Vet Rec 155, 667-671
LASCELLES, B. D., P. J. CRIPPS, A. JONES u. A. E. WATERMAN-PEARSON (1998):
Efficacy and kinetics of carprofen, administered preoperatively or postoperatively, for the prevention of pain in dogs undergoing ovariohysterectomy.
Vet Surg 27, 568-582 LEMKE, K. A. (2004):
Understanding the pathophysiology of perioperative pain.
Can Vet J 45, 405-413
LESHER, G. Y., E. J. FROELICH, M. D. GRUETT, J. H. BAILEY u. R. P.
BRUNDAGE (1962):
1,8-NAPHTHYRIDINE DERIVATIVES. A NEW CLASS OF CHEMOTHERAPEUTIC AGENTS.
J Med Pharm Chem 91, 1063-1065
LU, H. R., E. VLAMINCKX, A. VAN DE WATER, J. ROHRBACHER, A. HERMANS u.
D. J. GALLACHER (2007):
In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation.
Eur J Pharmacol 577, 222-232
LUNA, S. P., A. C. BASILIO, P. V. STEAGALL, L. P. MACHADO, F. Q. MOUTINHO, R. K. TAKAHIRA u. C. V. BRANDAO (2007):
Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs.
Am J Vet Res 68, 258-264
MANDEMA, J. W., E. TUKKER u. M. DANHOF (1991):
Pharmacokinetic-pharmacodynamic modelling of the EEG effects of midazolam in individual rats: influence of rate and route of administration.
Br J Pharmacol 102, 663-668
MAZZEI, D., J. ACCARDO, A. FERRARI u. A. PRIMAVERA (2012):
Levofloxacin neurotoxicity and non-convulsive status epilepticus (NCSE): a case report.
Clin Neurol Neurosurg 114, 1371-1373
MCCONNELL, J., R. KIRBY u. E. RUDLOFF (2007):
Administration of acepromazine maleate to 31 dogs with a history of seizures.
J Vet Emerg Crit Care 17, 262-267
MCKELLAR, Q., T. PEARSON, J. BOGAN, E. GAIBRAITH, P. LEES, B. LUDWIG u.
M. TIBERGHIEN (1990):
Pharmacokinetics, tolerance and serum thromboxane inhibition of carprofen in the dog.
J Small Anim Pract 31, 443-448
MEHLHORN, A. J. u. D. A. BROWN (2007):
Safety concerns with fluoroquinolones.
Ann Pharmacother 41, 1859-1866 MELVANI, S. u. B. R. SPEED (2000):
Alatrofloxacin-induced seizures during slow intravenous infusion.
Ann Pharmacother 34, 1017-1019
MITRA, J., C. P. O'BRIEN u. H. A. SLOVITER (1981):
The effects of methadone on cortical and subcortical EEG in the rat.
Electroencephalogr Clin Neurophysiol 52, 345-352 MODAI, J. (1989):
Treatment of serious infections with intravenous ciprofloxacin. French Multicenter Study Group.
Am J Med 87, 243s-247s
MOOLA, S., L. HAGBERG, G. A. CHURCHYARD, J. S. DYLEWSKI, S. SEDANI u.
H. STALEY (1999):
A multicenter study of grepafloxacin and clarithromycin in the treatment of patients with community-acquired pneumonia.
Chest 116, 974-983
MOORER, J. D., H. A. TOWLE-MILLARD, M. E. GROSS u. M. E. PAYTON (2013):
Effects of ampicillin/sulbactam and enrofloxacin on the blood pressure of isoflurane anesthetized dogs.
J Am Anim Hosp Assoc 49, 293-300 MÜLLER, N. (2013):
The role of anti-inflammatory treatment in psychiatric disorders.
Psychiatr Danub 25, 292-298
MURRELL, J., E. GRANDEMANGE, F. WOEHRLE, J. MENARD u. K. WHITE (2014):
Clinical efficacy and tolerability of cimicoxib in dogs with osteoarthritis: a multicentre prospective study.
Open J Vet Med 2014, 78 - 90 NABER, K. u. D. ADAM (1998):
die Expertengruppe der Paul-Ehrlich-Gesellschaft für Chemotherapie eV Einteilung der Fluorchinolone.
Chemother J 7, 66-68
NEUMANN, N. J., A. BLOTZ, G. WASINSKA-KEMPKA, M. ROSENBRUCH, P.
LEHMANN, H. J. AHR u. H. W. VOHR (2005):
Evaluation of phototoxic and photoallergic potentials of 13 compounds by different in vitro and in vivo methods.
J Photochem Photobiol B 79, 25-34
NOACHTAR, S., C. BINNIE, J. EBERSOLE, F. MAUGUIERE, A. SAKAMOTO u. B.
WESTMORELAND (1999):
A glossary of terms most commonly used by clinical electroencephalographers and proposal for the report form for the EEG findings. The International Federation of Clinical Neurophysiology.
Electroencephalogr Clin Neurophysiol Suppl 52, 21-41
OGINO, T., Y. MIZUNO, T. OGATA u. Y. TAKAHASHI (2005):
Pharmacokinetic interactions of flunixin meglumine and enrofloxacin in dogs.
Am J Vet Res 66, 1209-1213
OWENS, J. G., S. G. KAMERLING u. S. A. BARKER (1995):
Pharmacokinetics of ketoprofen in healthy horses and horses with acute synovitis.
J Vet Pharmacol Ther 18, 187-195
PARADIS, M., L. ABBEY, B. BAKER, M. COYNE, M. HANNIGAN, D. JOFFE, B.
PUKAY, A. TRETTIEN, S. WAISGLASS u. J. WELLINGTON (2001):
Evaluation of the clinical efficacy of marbofloxacin (Zeniquin) tablets for the treatment of canine pyoderma: an open clinical trial.
Vet Dermatol 12, 163-169
PELLEGRINO, F. C. u. R. E. SICA (2004):
Canine electroencephalographic recording technique: findings in normal and epileptic dogs.
Clin Neurophysiol 115, 477-487
PEREIRA-LEITE, C., C. NUNES u. S. REIS (2013):
Interaction of nonsteroidal anti-inflammatory drugs with membranes: in vitro assessment and relevance for their biological actions.
Prog Lipid Res 52, 571-584
PILLET, F., C. MONTREUIL, O. ROY, E. GRANDEMANGE u. F. WOEHRLE (2013):
Field experience with a single intravenous injection of marbofloxacin 16% in lactating dairy cows with acute clinical mastitis.
Rev Med Vet 164, 537-545
PONCELOT, L. u. R. POMA (2013):
Electrophysiology.
In: BSAVA Manuel of Canine and Feline Neurology
4. Aufl., British Small Animal Veterinary Association, Gloucester, S. 59 - 76
PRABHAKAR, H., Z. ALI, P. K. BITHAL, G. P. RATH, D. SINGH u. H. H. DASH (2009):
Isoflurane and sevoflurane decrease entropy indices more than halothane at equal MAC values.
J Anesth 23, 154-157
PRICE, J. u. A. NOLAN (2011):
The physiology and pathophysiology of pain.
In: BSAVA Manuel of Canine and Feline Anaesthesia and Analgesia 2. Aufl., British Small Animal Veterinary Association, Waterwells, S. 79 - 103
PROSSER, B. L. u. G. BESKID (1995):
Multicenter in vitro comparative study of fluoroquinolones against 25,129 gram-positive and gram-negative clinical isolates.
Diagn Microbiol Infect Dis 21, 33-45
REDDING, R. W. (1978):
Nonsteroidal anti-inflammatory drug-induced duodenal ulceration and perforation in a mature rottweiler.
Can Vet J 43, 971-972
REID, J., A. NOLAN, J. HUGHES, D. LASCELLES, P. PAWSON u. E. SCOTT (2007):
Development of the short-form Glasgow Composite Measure Pain Scale (CMPS-SF) and derivation of an analgesic intervention score.
Anim Welf 16, 97-104
REID, J., M. L. WISEMAN-ORR, E. M. SCOTT u. A. M. NOLAN (2013):
Development, validation and reliability of a web-based questionnaire to measure health-related quality of life in dogs.
J Small Anim Pract 54, 227-233
REIMER, M. E., S. A. JOHNSTON, M. S. LEIB, R. B. DUNCAN, JR., D. C. REIMER, M. MARINI u. K. GIMBERT (1999):
The gastroduodenal effects of buffered aspirin, carprofen, and etodolac in healthy dogs.
J Vet Intern Med 13, 472-477
RESNICK, D. K., S. H. GRAHAM, C. E. DIXON u. D. W. MARION (1998):
Role of cyclooxygenase 2 in acute spinal cord injury.
J Neurotrauma 15, 1005-1013
REUS, A. A., M. USTA, J. D. KENNY, P. J. CLEMENTS, I. PRUIMBOOM-BREES, M.
AYLOTT, A. M. LYNCH u. C. A. KRUL (2012):
The in vivo rat skin photomicronucleus assay: phototoxicity and photogenotoxicity evaluation of six fluoroquinolones.
Mutagenesis 27, 721-729
RUBIN, J., R. D. WALKER, K. BLICKENSTAFF, S. BODEIS-JONES u. S. ZHAO (2008):
Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
Vet Microbiol 131, 164-172 RUBINSTEIN, E. (2001):
History of quinolones and their side effects.
SAADY, A. u. R. G. HICKS (1980):
The effects of althesin on the electroencephalograph.
Anaesth Intensive Care 8, 206-210
SALETU, B., J. GRUNBERGER, R. AMREIN u. M. SKRETA (1981):
Assessment of pharmacodynamics of a new "controlled release" form of diazepam (Valium CR Roche) by quantitative EEG and psychometric analysis in neurotic subjects.
J Int Med Res 9, 408-433
SCHELLER, M. S., K. NAKAKIMURA, J. E. FLEISCHER u. M. H. ZORNOW (1990):
Cerebral effects of sevoflurane in the dog: comparison with isoflurane and enflurane.
Br J Anaesth 65, 388-392
SCHMASSMANN, A., G. ZOIDL, B. M. PESKAR, B. WASER, D. SCHMASSMANN-SUHIJAR, J. O. GEBBERS u. J. C. REUBI (2006):
Role of the different isoforms of cyclooxygenase and nitric oxide synthase during gastric ulcer healing in cyclooxygenase-1 and -2 knockout mice.
Am J Physiol Gastrointest Liver Physiol 290, G747-756 SCHRIER, R. W. (2009):
Manual of nephrology.
7th, Lippincott Williams & Wilkins, Philadelphia, S. 156
SEGEV, S., M. REHAVI u. E. RUBINSTEIN (1988):
Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.
Antimicrob Agents Chemother 32, 1624-1626
SEIBERT, K., Y. ZHANG, K. LEAHY, S. HAUSER, J. MASFERRER, W. PERKINS, L.
LEE u. P. ISAKSON (1994):
Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.
Proc Natl Acad Sci U S A 91, 12013-12017
SETO, Y., R. INOUE, M. OCHI, G. GANDY, S. YAMADA u. S. ONOUE (2011):
Combined use of in vitro phototoxic assessments and cassette dosing pharmacokinetic study for phototoxicity characterization of fluoroquinolones.
AAPS J 13, 482-492
SEYBOLD, V. S., Y. P. JIA u. L. G. ABRAHAMS (2003):
Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation.
Pain 105, 47-55
SHARKEY, M. (2013):
The challenges of assessing osteoarthritis and postoperative pain in dogs.
AAPS J 15, 598-607
SHAW, P. J., P. E. GANEY u. R. A. ROTH (2009):
Trovafloxacin enhances the inflammatory response to a negative or a Gram-positive bacterial stimulus, resulting in neutrophil-dependent liver injury in mice.
J Pharmacol Exp Ther 330, 72-78
SIMON, L. S., A. L. WEAVER, D. Y. GRAHAM, A. J. KIVITZ, P. E. LIPSKY, R. C.
HUBBARD, P. C. ISAKSON, K. M. VERBURG, S. S. YU, W. W. ZHAO u. G. S. GEIS (1999):
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
Aspirin selectively inhibits prostaglandin production in human platelets.
Nat New Biol 231, 235-237
SPRENG, M., J. DELEFORGE, V. THOMAS, B. BOISRAME u. H. DRUGEON (1995):
Antibacterial activity of marbofloxacin. A new fluoroquinolone for veterinary use against canine and feline isolates.
J Vet Pharmacol Ther 18, 284-289 STEISS, J. E. (1988):
A survey of current techniques in veterinary electrodiagnostics: EEG, spinal evoked and brainstem auditory evoked potential recording.
Vet Res Commun 12, 281-288 STEWART, L. F. (1957):
Chlorpromazine: use to activate electroencephalographic seizure patterns.
STREPPA, H. K., C. J. JONES u. S. C. BUDSBERG (2002):
Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs in canine blood.
Am J Vet Res 63, 91-94
SUAREZ, M. A., B. T. DZIKITI, F. G. STEGMANN u. M. HARTMAN (2012):
Comparison of alfaxalone and propofol administered as total intravenous anaesthesia for ovariohysterectomy in dogs.
Vet Anaesth Analg 39, 236-244
SURDYK, K. K., D. L. SLOAN u. S. A. BROWN (2012):
Renal effects of carprofen and etodolac in euvolemic and volume-depleted dogs.
Am J Vet Res 73, 1485-1490
TAKAHAMA, H. u. H. TAZAKI (2007):
Tosufloxacin tosilate-induced thrombocytopenic purpura.
J Dermatol 34, 465-467
TAKAYAMA, S., M. HIROHASHI, M. KATO u. H. SHIMADA (1995):
Toxicity of quinolone antimicrobial agents.
J Toxicol Environ Health 45, 1-45
TAKEDA, K., S. SAWAMURA, H. TAMAI, H. SEKIYAMA u. K. HANAOKA (2005):
Role for cyclooxygenase 2 in the development and maintenance of neuropathic pain and spinal glial activation.
Anesthesiology 103, 837-844
TAKIZAWA, T., K. HASHIMOTO, T. MINAMI, S. YAMASHITA u. K. OWEN (1999):
The comparative arthropathy of fluoroquinolones in dogs.
Hum Exp Toxicol 18, 392-399
TOBIAS, K. M., K. MARIONI-HENRY u. R. WAGNER (2006):
A retrospective study on the use of acepromazine maleate in dogs with seizures.
J Am Anim Hosp Assoc 42, 283-289
TOMMASINO, C., T. MAEKAWA, H. M. SHAPIRO, J. KEIFER-GOODMAN u. R. W.
KOHLENBERGER (1984):
Fentanyl-induced seizures activate subcortical brain metabolism.
Anesthesiology 60, 283-290
TOUTAIN, P. L. u. P. LEES (2004):
Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine.
J Vet Pharmacol Ther 27, 467-477
TRAEGER, S. M., M. F. BONFIGLIO, J. A. WILSON, B. R. MARTIN u. N. A.
Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes.
Antimicrob Agents Chemother 32, 190-194
TSUTOMI, Y., K. MATSUBAYASHI u. K. AKAHANE (1994):
Quantitation of GABAA receptor inhibition required for quinolone-induced convulsions in mice.
J Antimicrob Chemother 34, 737-746 VANE, J. R. (1971):
Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.
Nat New Biol 231, 232-235
VANE, J. R. u. R. M. BOTTING (1995):
New insights into the mode of action of anti-inflammatory drugs.
Inflamm Res 44, 1-10
VETOQUINOL GmbH, Ravensburg (2009):
Gebrauchsinformation Marbocyl FD 1 %.
Vetoquinol GmbH, Ravensburg
VILA, J., J. RUIZ, P. GONI u. M. T. DE ANTA (1996):
Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.
Antimicrob Agents Chemother 40, 491-493
VONDERHAAR, M. A. u. S. K. SALISBURY (1993):
Gastroduodenal ulceration associated with flunixin meglumine administration in three dogs.
J Am Vet Med Assoc 203, 92-95
WANG, B., Q. BAI, X. JIAO, E. WANG u. P. F. WHITE (1997):
Effect of sedative and hypnotic doses of propofol on the EEG activity of patients with or without a history of seizure disorders.
J Neurosurg Anesthesiol 9, 335-340
WARD-MCQUAID, J., D. JICHLINSKI u. R. MACIS (1963):
Nalidixic acid in urinary infections.
Br Med J 2, 1311
WATSON, A. D., D. B. CHURCH u. A. J. FAIRBURN (1981):
Postprandial changes in plasma urea and creatinine concentrations in dogs.
Am J Vet Res 42, 1878-1880
WELSH, E. M., A. M. NOLAN u. J. REID (1997):
WELSH, E. M., A. M. NOLAN u. J. REID (1997):